QuantuMDx, U of London Lead New Malaria Dx Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – A new consortium has been launched in Europe with the goal of developing a handheld molecular diagnostic device to test for malaria.

The Nanomal project is led by researchers at St. George's, University College London and molecular diagnostics firm QuantuMDx and has been provided with funding of €5.2 million ($6.7 million) from the European Commission's Seventh Framework Programme. Other participants in the consortium include the University of Tuebingen in Germany and the Karolinska Institute in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.